# Shanghai Zhongshan Hospital: Observational study in Uterine Hemorrhage, Cardiovascular Diseases (1308 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Shanghai Zhongshan Hospital |
| Sponsor type | Academic and hospital |
| Study | A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular Surgery |
| NCT ID | NCT07870941 |
| Phase | Observational |
| Status | recruiting |
| Conditions | Uterine Hemorrhage; Cardiovascular Diseases; Antithrombotic Drugs |
| Intervention types | drug |
| Target enrollment | 1308 |
| Site countries | China |
| Posted | 2026-10-13 |
| Planned start | 2026-09-16 |
| Event | Newly registered study |
| Event date | 2026-10-13 |

## Why this score
- 1308 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07870941). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.